The DACRIN strategic plan 2024 – 2029 builds on the successes of past and current collaborative research activities. We will continue to grow and strengthen our network through a strategic approach to research, communication, and partnerships.
Expanded and enhanced evidence-informed practice that improves the safety, efficiency, clinical outcomes and client experiences of alcohol and other drug (AOD) services.
To facilitate the conduct of quality AOD clinical research and improvement activities by enhancing collaboration between clinicians, consumers and researchers.
Priority 1: Lead drug and alcohol clinical research
Our agenda is collaborative, diverse, rigorous, and driven by clinical needs and consumer priorities.
Priority 2: Build clinical research and translation capacity
Our network has the capacity to produce practice-changing outcomes.
Priority 3: Expand the network and influence change
Our inclusive network is recognised for its contributions to AOD clinical research.
DACRIN’s research priorities guide our endorsement decisions and collaborative initiatives. Developed through consultation with Council members and affiliates, they reflect the sector’s collective voice and aim to improve AOD care across NSW.
Through our Strategic Plan DACRIN is committed to:
Explore our recent progress through the annual reports below. Each report contains summaries of milestones, achievements and successes.
DACRIN annual progress report 2024
DACRIN achievements 2022-2023
DACRIN achievements 2019-2021